Longeviti Introduces Brain Ultrasound Interface Solution

Longeviti Neuro Solutions has launched ClearFit AI, a brain ultrasound interface (BUI). Together, these technologies create a persistent acoustic interface to the brain, enabling real-time bedside imaging and supporting future advances in artificial intelligence (AI)-assisted neurosurgical care.

The ClearFit AI platform combines: ClearFit sonolucent cranial implants, ultrasound compatibility, clinical workflow and training support, and AI-enhanced imaging.

This platform enables the (BUI)—a new category of post-operative neurological access that may reduce reliance on computed tomography (CT) and MRI transport, integrate into existing neurological workflows, and position the implant site as a potential foundation for future applications currently under investigation.

As healthcare systems continue to evaluate scalable and cost-conscious technologies, ultrasound-enabled imaging approaches may offer operational advantages in select care environments.

Adjunct imaging technologies may contribute to:

• Expanded bedside visualization capabilities
• Reduce operational transport burdens
• Increased accessibility to imaging technologies
• Imaging workflow efficiency and process optimization

Any future clinical, operational, or economic benefits will depend on regulatory review, validation activities, adoption patterns, and real-world implementation.

For clinicians, BUI means the ability to assess the brain at the bedside—possibly reducing operational burdens such as scheduling imaging, transporting a post-operative patient, or waiting for results. ClearFit AI makes that possible by turning the implant site into a persistent sonolucent interface, with AI-assisted imaging optimization available only on Clarius Ultrasound units.

For patients, that access may mean fewer trips to the scanner, less radiation exposure, and bedside visualization that may extend from the ICU into outpatient and recovery settings.

“The mission was always in the name,” Longeviti Neuro Solutions CEO Jesse Christopher stated. “Longeviti exists to pursue scalable platform technologies that help create new possibilities for clinicians, researchers, and patients while supporting the broader goal of protecting cognitive function and improving quality of life.”

Longeviti Neuro Solutions is a U.S.-based neurotechnology company developing neurosurgical platform solutions. Its ClearFit AI, a BUI, unlocks post-operative ultrasound access to the brain, giving clinicians visibility into recovery. Longeviti Neuro Solutions designs and manufactures ultrasound-penetrable U.S. Food and Drug Administration-cleared implants that power the ClearFit AI platform, allowing bedside, AI-assisted ultrasound imaging and visualization, and post-operative neurosurgical care.